Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reina N Fuji

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Science Translational Medicine|May 3, 2013
Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrierJessica A Couch, Y Joy Yu, Yin Zhang, et al.
British Journal of Pharmacology|September 1, 2017
Widespread brain distribution and activity following i.c.v. infusion of anti-β-secretase (BACE1) in nonhuman primatesDaniela Bumbaca Yadav, Janice A Maloney, Kristin R Wildsmith, et al.
Cancer Research|March 5, 2009
Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selectionAndrew G Polson, Jill Calemine-Fenaux, Pamela Chan, et al.
Science Translational Medicine|February 6, 2015
Effect of selective LRRK2 kinase inhibition on nonhuman primate lungReina N Fuji, Michael Flagella, Miriam Baca, et al.
Nature Biotechnology|January 24, 2012
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesBen-Quan Shen, Keyang Xu, Luna Liu, et al.
Science Translational Medicine|April 24, 2020
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsMarco A S Baptista, Kalpana Merchant, Ted Barrett, et al.
Science Translational Medicine|May 13, 2021
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's diseaseGai Ayalon, Seung-Hye Lee, Oskar Adolfsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 1, 2024
Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonismStephen P Schauer, Chang Hoon Cho, Gloriia Novikova, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Science Translational Medicine|May 3, 2013
Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrierJessica A Couch, Y Joy Yu, Yin Zhang, et al.
British Journal of Pharmacology|September 1, 2017
Widespread brain distribution and activity following i.c.v. infusion of anti-β-secretase (BACE1) in nonhuman primatesDaniela Bumbaca Yadav, Janice A Maloney, Kristin R Wildsmith, et al.
Cancer Research|March 5, 2009
Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selectionAndrew G Polson, Jill Calemine-Fenaux, Pamela Chan, et al.
Science Translational Medicine|February 6, 2015
Effect of selective LRRK2 kinase inhibition on nonhuman primate lungReina N Fuji, Michael Flagella, Miriam Baca, et al.
Nature Biotechnology|January 24, 2012
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesBen-Quan Shen, Keyang Xu, Luna Liu, et al.
Science Translational Medicine|April 24, 2020
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsMarco A S Baptista, Kalpana Merchant, Ted Barrett, et al.
Science Translational Medicine|May 13, 2021
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's diseaseGai Ayalon, Seung-Hye Lee, Oskar Adolfsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 1, 2024
Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonismStephen P Schauer, Chang Hoon Cho, Gloriia Novikova, et al.
Pageof 3